4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-045749
Chief Executive Officer sold 7,800 shares at an average $37.43 ($291,957)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ciechanover Isaac E. Chief Executive Officer | 2018-08-06 | Sale | −3,900 | $37.48 | $146,172 | 85,978 | I: show line 1 in the form |
| Ciechanover Isaac E. Chief Executive Officer | 2018-08-07 | Sale | −3,600 | $37.35 | $134,460 | 82,378 | I: show line 2 in the form |
| Ciechanover Isaac E. Chief Executive Officer | 2018-08-07 | Sale | −300 | $37.75 | $11,325 | 82,078 | I: show line 3 in the form |
| Open-market sales · 7,800 sh · avg $37.43 · $291,957 | |||||||
Loading xslF345X03/doc4.xml…